As of 2025-12-28, the Relative Valuation of Puma Biotechnology Inc (PBYI) is 13.83 USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.16 USD, the upside of Puma Biotechnology Inc based on Relative Valuation is 124.5%.
The range of the Relative Valuation is 9.33 - 17.67 USD.
| Range | Selected | |
| Trailing P/E multiples | 19.5x - 24.1x | 21.8x |
| Forward P/E multiples | 22.0x - 32.9x | 27.4x |
| Fair Price | 9.33 - 17.67 | 13.83 |
| Upside | 51.5% - 186.9% | 124.5% |
| Date | P/E |
| 2025-12-26 | 8.39 |
| 2025-12-24 | 8.12 |
| 2025-12-23 | 8.05 |
| 2025-12-22 | 7.94 |
| 2025-12-19 | 7.67 |
| 2025-12-18 | 7.66 |
| 2025-12-17 | 7.60 |
| 2025-12-16 | 7.73 |
| 2025-12-15 | 7.93 |
| 2025-12-12 | 7.99 |
| 2025-12-11 | 7.81 |
| 2025-12-10 | 7.62 |
| 2025-12-09 | 7.52 |
| 2025-12-08 | 7.36 |
| 2025-12-05 | 7.22 |
| 2025-12-04 | 7.21 |
| 2025-12-03 | 7.07 |
| 2025-12-02 | 6.64 |
| 2025-12-01 | 6.76 |
| 2025-11-28 | 6.88 |
| 2025-11-26 | 6.88 |
| 2025-11-25 | 6.75 |
| 2025-11-24 | 6.79 |
| 2025-11-21 | 6.66 |
| 2025-11-20 | 6.60 |
| 2025-11-19 | 6.66 |
| 2025-11-18 | 6.90 |
| 2025-11-17 | 6.76 |
| 2025-11-14 | 6.66 |
| 2025-11-13 | 6.75 |
| 2025-11-12 | 6.80 |
| 2025-11-11 | 7.07 |
| 2025-11-10 | 6.45 |
| 2025-11-07 | 8.16 |
| 2025-11-06 | 6.68 |
| 2025-11-05 | 6.74 |
| 2025-11-04 | 6.68 |
| 2025-11-03 | 6.87 |
| 2025-10-31 | 6.95 |
| 2025-10-30 | 7.44 |
| 2025-10-29 | 7.03 |
| 2025-10-28 | 7.15 |
| 2025-10-27 | 7.18 |
| 2025-10-24 | 7.13 |
| 2025-10-23 | 6.87 |
| 2025-10-22 | 7.13 |
| 2025-10-21 | 7.05 |
| 2025-10-20 | 7.43 |
| 2025-10-17 | 7.45 |
| 2025-10-16 | 7.37 |